Literature DB >> 3668820

Extended least squares (ELS) for pharmacokinetic models.

C M Metzler1.   

Abstract

An important part of pharmacokinetic research is fitting models to observed data and estimating the parameters in the model. In general, parameter estimation in pharmacokinetics is a subset of the general problem of nonlinear regression or parameter estimation in nonlinear regression models. The same criteria, algorithms, and software used in other areas of science have been used in pharmacokinetics. Nonlinear modeling is a difficult mathematical and statistical task, often presenting problems. Any proposed new tool is of interest, and extended least squares (ELS) has been suggested as being better than the methods usually used. This suggestion and the evidence supporting it are examined; additional simulations are reported. With the evidence presently available, ELS does not seem to be superior to traditional least squares methods.

Mesh:

Year:  1987        PMID: 3668820     DOI: 10.1002/jps.2600760716

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  A comparison of methods for estimating individual pharmacokinetic parameters.

Authors:  T Amisaki; S Eguchi
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

2.  Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses.

Authors:  M O Karlsson; A Lindberg-Freijs
Journal:  J Pharmacokinet Biopharm       Date:  1990-08

3.  Pharmacokinetic parameter estimations by minimum relative entropy method.

Authors:  T Amisaki; S Eguchi
Journal:  J Pharmacokinet Biopharm       Date:  1995-10

Review 4.  Methodological issues in pharmacokinetic-pharmacodynamic modelling.

Authors:  E Bellissant; V Sébille; G Paintaud
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

5.  The influence of assay variability on pharmacokinetic parameter estimation.

Authors:  D A Graves; C S Locke; K T Muir; R P Miller
Journal:  J Pharmacokinet Biopharm       Date:  1989-10

6.  MicroPharm-K, a microcomputer interactive program for the analysis and simulation of pharmacokinetic processes.

Authors:  S Urien
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

7.  Nonlinearity of amoxicillin absorption kinetics in human.

Authors:  G Paintaud; G Alván; M L Dahl; A Grahnén; J Sjövall; J O Svensson
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 8.  Paediatric labelling requirements. Implications for pharmacokinetic studies.

Authors:  J T Wilson; G L Kearns; D Murphy; S J Yaffe
Journal:  Clin Pharmacokinet       Date:  1994-04       Impact factor: 6.447

9.  Pharmacokinetics of methylergometrine in the rat: evidence for enterohepatic recirculation by a linked-rat model.

Authors:  U Bredberg; L Paalzow
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

Review 10.  Statistical considerations in pharmacokinetic study design.

Authors:  J D Powers
Journal:  Clin Pharmacokinet       Date:  1993-05       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.